Skip to Main Content

Author Details

Geoff Macintyre
CRUK Cambridge Institute, University of Cambridge
2009
43
18
PMIDPaper TitleJournal TitlePublished Year
36849656A medley of resistance in ovarian cancers.Nat Genet2023
37752102Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
37474499The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.Nat Commun2023
35640971CNpare: matching DNA copy number profiles.Bioinformatics2022
35705807A pan-cancer compendium of chromosomal instability.Nature2022
35437272Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.Int J Gynecol Cancer2022
35398881The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.Clin Cancer Res2022
34108644MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.Prostate Cancer Prostatic Dis2021
33570999FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.JCO Clin Cancer Inform2021
34322653Loss of <i>SNAI2</i> in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.JCO Precis Oncol2021
32483290Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.Nat Genet2020
32366847Genomic landscape of platinum resistant and sensitive testicular cancers.Nat Commun2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
29592867Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.Endocr Relat Cancer2018
30104763Copy number signatures and mutational processes in ovarian carcinoma.Nat Genet2018
27864419How Subclonal Modeling Is Changing the Metastatic Paradigm.Clin Cancer Res2017
28359078Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.Br J Cancer2017
26812572A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.Br J Cancer2016
27653089Comparing nodal versus bony metastatic spread using tumour phylogenies.Sci Rep2016
27120785Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.Oncotarget2016
27478068Sequencing Structural Variants in Cancer for Precision Therapeutics.Trends Genet2016
26681675Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples.Ann Oncol2016
25827447Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.Nat Commun2015
24085599Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology.Clin Exp Metastasis2014
25356597Establishing and managing a global student network.PLoS Comput Biol2014
25374782Associating disease-related genetic variants in intergenic regions to the genes they impact.PeerJ2014
24784875Paving the way towards a successful and fulfilling career in computational biology.PLoS Comput Biol2014
24771644Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.Clin Cancer Res2014
24586140Workshops: a great way to enhance and supplement a degree.PLoS Comput Biol2014
24705338Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.PLoS One2014
24389656Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads.Bioinformatics2014
24447442Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array.BMC Genomics2014
23770079Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.Cell Stem Cell2013
24282392Breaking the ice and forging links: the importance of socializing in research.PLoS Comput Biol2013
24278001Ten simple rules for starting a regional student group.PLoS Comput Biol2013
24098107The regional student group program of the ISCB student council: stories from the road.PLoS Comput Biol2013
24068913ISCB computational biology Wikipedia competition.PLoS Comput Biol2013
24244148The young PI buzz: learning from the organizers of the Junior Principal Investigator Meeting at ISMB-ECCB 2013.PLoS Comput Biol2013
21890681Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.Genome Res2011
20860844A bi-ordering approach to linking gene expression with clinical annotations in gastric cancer.BMC Bioinformatics2010
20823317is-rSNP: a novel technique for in silico regulatory SNP detection.Bioinformatics2010
19208118A voting approach to identify a small number of highly predictive genes using multiple classifiers.BMC Bioinformatics2009
  • 1 - 43 of 43

Recommended Authors

Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)
Career Start Year 2016
Number of shared co-authors 3
Institute of Molecular Medicine, Feinstein Institutes for Medical Research
Career Start Year 2010
Number of shared co-authors 1
Brigham Young University
Career Start Year 2008
Number of shared co-authors 0
T.J. Watson Research Center
Career Start Year 2008
Number of shared co-authors 0
University of Trento
Career Start Year 2008
Number of shared co-authors 0
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 17
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
University of Washington
Career Start Year 2006
Number of shared co-authors 4
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 39
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 2
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 5
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 4
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 6
Washington University
Career Start Year 2003
Number of shared co-authors 7
University of California
Career Start Year 2003
Number of shared co-authors 1
Washington University
Career Start Year 2003
Number of shared co-authors 6
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 8
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 13
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 22
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 14
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 3
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 40
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 56
University of British Columbia
Career Start Year 1995
Number of shared co-authors 19
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
The Ohio State University
Career Start Year 1988
Number of shared co-authors 11
University of California los angeles
Career Start Year 1970
Number of shared co-authors 19
University of Trento
Career Start Year 1969
Number of shared co-authors 2

Collaborators

CRUK Cambridge Institute, University of Cambridge
Co-authored papers 13
Royal Melbourne Hospital, The University of Melbourne
Co-authored papers 12
Royal Melbourne Hospital, The University of Melbourne
Co-authored papers 12
Royal Melbourne Hospital
Co-authored papers 10
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 9
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 9
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 9
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
CRUK Clinical Trials Unit, University of Glasgow
Co-authored papers 6
University of Cambridge
Co-authored papers 5
University of Glasgow
Co-authored papers 4
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 4
Australian Prostate Cancer Research Centre Epworth
Co-authored papers 4
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 4
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Barts Health NHS Trust
Co-authored papers 3
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
The Netherlands Cancer Institute
Co-authored papers 3
The Francis Crick Institute
Co-authored papers 3
Peter MacCallum Cancer Centre
Co-authored papers 2
Peter MacCallum Cancer Centre
Co-authored papers 2
Instituto de Salud Carlos III
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Rollins School of Public Health, Emory University
Co-authored papers 2
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 2
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 2
University of Cambridge
Co-authored papers 2
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 2
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 2